<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00099</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=24 g=1 f=1 --> 7. Large-volume nebulizers and mist tents  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 8. Other Devices  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Interruption of Person-to-Person Transmission of Bacteria  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Handwashing  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Barrier Precautions  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Care of Patients with Tracheostomy  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. Suctioning of Respiratory Tract Secretions  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> III. Modifying Host Risk for Infection  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Precautions for Prevention of Endogenous Pneumonia  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Prevention of Aspiration  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Prevention of Gastric Colonization  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Prevention of Postoperative Pneumonia  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> C. Other Prophylactic Procedures for Pneumonia  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Vaccination of Patients  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Systemic Antimicrobial Prophylaxis  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Use of Rotating ``Kinetic'' Beds  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=71 g=1 f=1 --> Prevention and Control of Legionnaires' Disease  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> I. Staff Education and Infection Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Staff Education  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> II. Interruption of Transmission of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Legionella <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 -->  spp.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Primary Prevention (Preventing Nosocomial Legionnaires' Disease when No Cases have been Documented)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Nebulization and Other Devices  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Cooling Towers  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Water-Distribution System  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Secondary Prevention (Response to Identification of Laboratory-Confirmed Nosocomial Legionellosis)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=71 g=1 f=1 --> Prevention and Control of Nosocomial Pulmonary Aspergillosis  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> I. Staff Education and Infection Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Staff Education  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> II. Interruption of Transmission of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 -->  spp. Spores  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Planning New Specialized-Care Units for High-Risk Patients  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. In Existing Facilities with no Cases of Nosocomial Aspergillosis  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> C. When a Case of Nosocomial Aspergillosis Occurs  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> III. Modifying Host Risk for Infection  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=71 g=1 f=1 --> Prevention and Control of Respiratory Syncytial Virus (RSV)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> I. Staff Education and Infection Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Staff Education  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> II. Interruption of Transmission of RSV  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Prevention of Person-to-Person Transmission  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Primary Measures for Contact Isolation  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> a. Handwashing  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> b. Gloving <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> c. Gowning  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> d. Staffing  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> e. Limiting Visitors  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Control of RSV Outbreaks  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> a. Use of Private Room, Cohorting, and Patient-Screening  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> b. Personnel Cohorting  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> c. Postponing Patient Admission  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> d. Wearing Eye-Nose Goggles  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=71 g=1 f=1 --> Prevention and Control of Influenza  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> I. Staff Education and Infection Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Staff Education  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> II. Modifying Host Risk for Infection  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Vaccination  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Patients  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Personnel  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Use of Antiviral Agents  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> III. Interruption of (Person-to-Person) Transmission  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> IV. Control of Influenza Outbreaks  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Determining the Outbreak Strain  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> B. Vaccination of Patients and Personnel  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> C. Amantadine or Rimantadine Administration  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> D. Interruption of (Person-to-Person) Transmission  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            